Pancreatic Neuroendocrine Tumor, Lymphoma, and Squamous Cell Carcinoma of Larynx; Three Primary Cancers in One Patient: A Case Report

Abstract

received chemotherapy based on etoposide and cisplatin treatment. Malignant ascites was developed at 18.1 months after operation, and the patient passed away at postoperative 19.2 months. Conclusion: Surgical resection for pancreatic neuroendocrine carcinoma is genreally not recommended, because of dismal prognosis. Debulking resection with the removal of 90% of tumor voluem can be prolonged survival outcome, even though there is cutaneous metastasis.